A Study on the Effect of Renal Impairment on the Pharmacokinetics of RO4917838
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
This open-label, single-dose, parallel-group study will investigate the pharmacokinetics and
safety of RO4917838 in healthy and renal impaired subjects. Subjects will receive a single
dose of RO4917838.